Market Overview:
The global GAS pharyngitis diagnostics market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of GAS pharyngitis, rising demand for rapid and accurate diagnostic tests, and growing awareness about the benefits of early diagnosis and treatment. The global GAS pharyngitis diagnostics market is segmented on the basis of type, application, and region. On the basis of type, it is divided into rapid test kits, culture test kits, PCR-based test kits. On the basis of application, it is classified into physician clinics, diagnostic laboratories hospitals.
Product Definition:
GAS Pharyngitis Diagnostics is a diagnostic tool that helps identify group A Streptococcus (GAS), the bacteria responsible for strep throat, as the cause of pharyngitis. GAS pharyngitis is a common cause of sore throat and can lead to more serious health problems if left untreated. The use of GAS Pharyngitis Diagnostics can help ensure that patients receive appropriate treatment for their condition.
Rapid Test Kit:
Rapid test kits are used for the detection of Group A Streptococcus (GAS) in pharyngitis. These tests are also known to be useful in diagnosing other bacterial infections of the upper respiratory tract, including tonsillitis and pharyngo-tonsillitis.
Culture Test:
Culture Test is used for the diagnosis of Group A Streptococcus (GAS) pharyngitis. This test helps in classifying the type of bacteria causing pharyngitis and provides information regarding their antibiotic sensitivity.
This test also helps in monitoring the effectiveness of anti-bacterial treatment, as a positive culture can be treated with antibiotics while a negative one can be discharged if no infection is found.
Application Insights:
The market is segmented by application into a physician clinic, diagnostic laboratories, and hospitals. The hospital segment dominated the global gas pharyngitis diagnostics market in 2017 due to high usage of general anesthetics during surgeries. In addition, the rising prevalence of chronic diseases such as asthma and allergies is expected to drive demand for rapid test kits over the forecast period.
Rapid diagnosis of acute respiratory infections through point-of-care testing has become critical in recent years owing to increasing incidence rates globally. According to WHO data published in 2018, there were approximately 1 billion cases of acute respiratory infections (ARI) annually across the globe with about 300 million people becoming ill from these infections. Gas pharyngitis is one of the most common causes leading ARI; therefore, rapid diagnosis through point-of-care tests is critical for treatment success at a reasonable cost while maintaining efficiency within limited resources available for healthcare purposes worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high awareness levels coupled with relatively higher disease prevalence in this region as compared to other regions. Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing number of private sector players and rising investments by governments for development of healthcare infrastructure. Moreover, growing medical tourism due to availability of advanced treatments at affordable costs will drive regional demand during the forecast period.
Growth Factors:
- Increasing incidence of GAS pharyngitis
- Rising demand for rapid and accurate diagnosis of GAS pharyngitis
- Growing awareness about the benefits of early diagnosis and treatment of GAS pharyngitis
- Technological advancements in diagnostic methods for GAS pharyngitis
- increasing prevalence of chronic diseases such as diabetes and HIV/AIDS, which increase the risk for developing GAS pharyngitis
Scope Of The Report
Report Attributes
Report Details
Report Title
GAS Pharyngitis Diagnostics Market Research Report
By Type
Rapid Test Kit, Culture Test, PCR-based Test
By Application
Physician Clinics, Diagnostic Laboratories, Hospitals
By Companies
Quidel Corporation, BD, Abbott Laboratories, bioMérieux SA, F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc. (Danaher), Meridian Bioscience, Inc., DiaSorin S.p.A., Sekisui Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global GAS Pharyngitis Diagnostics Market Report Segments:
The global GAS Pharyngitis Diagnostics market is segmented on the basis of:
Types
Rapid Test Kit, Culture Test, PCR-based Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Physician Clinics, Diagnostic Laboratories, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Quidel Corporation
- BD
- Abbott Laboratories
- bioMérieux SA
- F. Hoffmann-La Roche Ltd
- Beckman Coulter, Inc. (Danaher)
- Meridian Bioscience, Inc.
- DiaSorin S.p.A.
- Sekisui Diagnostics
Highlights of The GAS Pharyngitis Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rapid Test Kit
- Culture Test
- PCR-based Test
- By Application:
- Physician Clinics
- Diagnostic Laboratories
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the GAS Pharyngitis Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
GAS Pharyngitis Diagnostics is a diagnostic company that specializes in the detection and diagnosis of Group A streptococcal (GAS) pharyngitis.
Some of the major companies in the gas pharyngitis diagnostics market are Quidel Corporation, BD, Abbott Laboratories, bioM©rieux SA, F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc. (Danaher), Meridian Bioscience, Inc., DiaSorin S.p.A., Sekisui Diagnostics.
The gas pharyngitis diagnostics market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 GAS Pharyngitis Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 GAS Pharyngitis Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 GAS Pharyngitis Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the GAS Pharyngitis Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global GAS Pharyngitis Diagnostics Market Size & Forecast, 2018-2028
4.5.1 GAS Pharyngitis Diagnostics Market Size and Y-o-Y Growth
4.5.2 GAS Pharyngitis Diagnostics Market Absolute $ Opportunity
Chapter 5 Global GAS Pharyngitis Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 GAS Pharyngitis Diagnostics Market Size Forecast by Type
5.2.1 Rapid Test Kit
5.2.2 Culture Test
5.2.3 PCR-based Test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global GAS Pharyngitis Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 GAS Pharyngitis Diagnostics Market Size Forecast by Applications
6.2.1 Physician Clinics
6.2.2 Diagnostic Laboratories
6.2.3 Hospitals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global GAS Pharyngitis Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 GAS Pharyngitis Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America GAS Pharyngitis Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America GAS Pharyngitis Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America GAS Pharyngitis Diagnostics Market Size Forecast by Type
9.6.1 Rapid Test Kit
9.6.2 Culture Test
9.6.3 PCR-based Test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America GAS Pharyngitis Diagnostics Market Size Forecast by Applications
9.10.1 Physician Clinics
9.10.2 Diagnostic Laboratories
9.10.3 Hospitals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe GAS Pharyngitis Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe GAS Pharyngitis Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe GAS Pharyngitis Diagnostics Market Size Forecast by Type
10.6.1 Rapid Test Kit
10.6.2 Culture Test
10.6.3 PCR-based Test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe GAS Pharyngitis Diagnostics Market Size Forecast by Applications
10.10.1 Physician Clinics
10.10.2 Diagnostic Laboratories
10.10.3 Hospitals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific GAS Pharyngitis Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific GAS Pharyngitis Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific GAS Pharyngitis Diagnostics Market Size Forecast by Type
11.6.1 Rapid Test Kit
11.6.2 Culture Test
11.6.3 PCR-based Test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific GAS Pharyngitis Diagnostics Market Size Forecast by Applications
11.10.1 Physician Clinics
11.10.2 Diagnostic Laboratories
11.10.3 Hospitals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America GAS Pharyngitis Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America GAS Pharyngitis Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America GAS Pharyngitis Diagnostics Market Size Forecast by Type
12.6.1 Rapid Test Kit
12.6.2 Culture Test
12.6.3 PCR-based Test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America GAS Pharyngitis Diagnostics Market Size Forecast by Applications
12.10.1 Physician Clinics
12.10.2 Diagnostic Laboratories
12.10.3 Hospitals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) GAS Pharyngitis Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) GAS Pharyngitis Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) GAS Pharyngitis Diagnostics Market Size Forecast by Type
13.6.1 Rapid Test Kit
13.6.2 Culture Test
13.6.3 PCR-based Test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) GAS Pharyngitis Diagnostics Market Size Forecast by Applications
13.10.1 Physician Clinics
13.10.2 Diagnostic Laboratories
13.10.3 Hospitals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 GAS Pharyngitis Diagnostics Market: Competitive Dashboard
14.2 Global GAS Pharyngitis Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Quidel Corporation
14.3.2 BD
14.3.3 Abbott Laboratories
14.3.4 bioMérieux SA
14.3.5 F. Hoffmann-La Roche Ltd
14.3.6 Beckman Coulter, Inc. (Danaher)
14.3.7 Meridian Bioscience, Inc.
14.3.8 DiaSorin S.p.A.
14.3.9 Sekisui Diagnostics
